3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
Dutasteride
4
Prostatectomy
2
proxalutamide
1
polyphenon E
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Therapeutics
1
Tamsulosin
1
Standard of Care
1
Risedronic Acid
1
Psychiatric Rehabilitation
1
Prostate-Specific Antigen
1
Oxygen
1
Nitrous Oxide
1
Needles
1
Microspheres
1
Lycopene
1
Levofloxacin
1
Electroacupuncture
1
Doxazosin
1
Dexmedetomidine
1
Celecoxib
1
Biopsy
1
Biofeedback, Psychology
1
Amyloid
1
Adrenergic alpha-Antagonists
1
Acupuncture Therapy
1
5-alpha Reductase Inhibitors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Prostatic Hyperplasia
×
Therapeutics
×
Clear all
NCT04272216
2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
99 enrolled
15 charts